SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,429,493 | -32.3% | 200,803 | -3.1% | 0.00% | -100.0% |
| Q2 2023 | $2,111,076 | +12.3% | 207,273 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,879,783 | +121726.5% | 207,273 | -3.7% | 0.00% | – |
| Q4 2022 | $1,543 | -99.8% | 215,238 | +54.7% | 0.00% | – |
| Q3 2022 | $906,000 | +61.5% | 139,119 | +19.5% | 0.00% | – |
| Q2 2022 | $561,000 | -4.6% | 116,442 | +12.5% | 0.00% | – |
| Q1 2022 | $588,000 | +21.2% | 103,534 | +7.0% | 0.00% | – |
| Q4 2021 | $485,000 | -8.0% | 96,747 | +22.1% | 0.00% | – |
| Q3 2021 | $527,000 | +93.0% | 79,265 | +76.8% | 0.00% | – |
| Q2 2021 | $273,000 | -12.2% | 44,827 | -4.4% | 0.00% | – |
| Q1 2021 | $311,000 | +25.4% | 46,878 | 0.0% | 0.00% | – |
| Q4 2020 | $248,000 | -24.8% | 46,878 | +6.0% | 0.00% | – |
| Q3 2020 | $330,000 | +70.1% | 44,234 | +67.9% | 0.00% | – |
| Q2 2020 | $194,000 | +65.8% | 26,350 | +66.0% | 0.00% | – |
| Q1 2020 | $117,000 | – | 15,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |